Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-02-12 @ 10:25 AM
Study NCT ID:
NCT04366232
Status:
TERMINATED
Last Update Posted:
2020-12-16
First Post:
2020-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020-CHITS-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None